Avantor, Inc. (AVTR)
About Avantor, Inc.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $6.6B
- Net income
- -$530.2M
- Total assets
- $11.8B
- Market cap
- $6.3B
- Gross margin
- 32.7%
- Operating margin
- -3.8%
- Net margin
- -8.1%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $6.6B
- Cost of revenue
- $4.4B
- Gross profit
- $2.1B
- Operating expenses
- $2.4B
- Operating income
- -$246.2M
- Income tax
- $88.9M
- Net income
- -$530.2M
- EPS (basic)
- $-0.78
- EPS (diluted)
- $-0.78
Balance sheet
- Total assets
- $11.8B
- Current assets
- $2.5B
- Total liabilities
- $6.2B
- Current liabilities
- $1.4B
- Shareholders’ equity
- $5.6B
Cash flow
- Operating cash flow
- $623.8M
- Investing cash flow
- -$130.5M
- Financing cash flow
- -$409.4M
- Net cash flow
- $103.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $6.3B
- EPS (diluted)
- $-0.78
- Shares outstanding
- 546.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 17, 2019
Avantor, Inc. (AVTR) Stock Price
- Reported a net loss of $530.2M in FY2025.
- Revenue declined 11% from FY2021 to FY2025.
- Gross margin of 32.7%, net margin -8.1%.
- Trading 27% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review Avantor, Inc..
Write a review
News about Avantor, Inc.
News & sentiment via Polygon.io
Avantor, Inc.: frequently asked questions
Is Avantor, Inc. an American company?
Avantor, Inc. is a US-based company headquartered in Radnor, Pennsylvania, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Avantor, Inc. headquartered?
Avantor, Inc. is headquartered in Radnor, Pennsylvania, United States.
Is Avantor, Inc. publicly traded?
Yes — Avantor, Inc. is a publicly traded company. Its stock trades under the ticker symbol AVTR on the NYSE.
What does Avantor, Inc. do?
Avantor, Inc. is an American Medical Devices company in the Health & Beauty sector.
